Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market’s growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine’s ability to bring relief to TRD sufferers has resulted in its increased use as a treatment option, sustaining market growth. According to MDPI, in May 2023, MDD is a common diagnosis, affecting an estimated 280 million people worldwide and 21 million adults in the US alone, and can lead to impaired functioning and increased risk of suicidality. The current treatments for MDD include pharmacotherapeutics, such as SSRIs and SNRIs, psychotherapy, and somatic treatments, such as electroconvulsive therapy. These treatments are generally effective for many patients, however, some patients don’t respond to treatment and are classified as having treatment-resistant depression (TRD). In addition, it can take several weeks to months for the effects of these treatments to take effect. Long-term administration is also typically needed in order to maintain therapeutic efficacy.
Get Free Sample link @ https://www.omrglobal.com/request-sample/ketamine-treatment-market
Furthermore,the high prevalence of TRD has highlighted the need for improved treatments. Ketamine has demonstrated potential as a beneficial treatment for a significant portion of individuals with TRD. As a result, it is a popular choice of treatment. In 2017, 8.9 million adults in the US were treated for MDD over twelve months, and 30.9%, or 2.8 million, of those were diagnosed with TRD. This increase in prevalence of TRD has created a social and fiscal burden, that highlights the need for more effective treatments and a better understanding of the mechanisms of depression.
full report of Ketamine treatment Market available @ https://www.omrglobal.com/industry-reports/ketamine-treatment-market
- Market Coverage
- Market number available for – 2023-2029
- Base year- 2022
- Forecast period- 2023-2029
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
- , and others
Market Segmentation
Global Ketamine Treatment Market by Route of Administration
- Oral
- Infusions
- Nasal Spray
Global Ketamine Treatment Market by Application
- Treatment-Resistant Depression (TRD)
- Anxiety Disorder
- Post-Traumatic Stress Disorder (PTSD)
- Others (Anesthesia and Sedation, Bipolar Depression, and Chronic Pain Management)
Global Ketamine Treatment Market by End-User
- Hospitals and Medical Centers
- Specialized Ketamine Clinics
- Psychiatric Hospitals
- Others (Rehabilitation Centers, Primary Care Physicians, Individual Patients and Research & Academic Institutions)
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Core One Labs Inc.
- Enso Discoveries, LLC.
- Johnson & Johnson Pvt. Ltd.
- Ketamine Research Institute
- Ketamine Wellness Centers
- Klarisana
- Koch Industries, Inc.
- Mindbloom, Inc.
- Pfizer
- co.uk
- Stella MSO LLC
- Unión Químico Farmacéutica, S.A.U.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global ketamine treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ketamine-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
